Cryoport (CYRX) Misses Q2 EPS by 19c; Offers FY23 Revenue Guidance

Cryoport (NASDAQ: CYRX) reported Q2 EPS of ($0.42), $0.19 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $57 million versus the consensus estimate of $68.81 million.

GUIDANCE:

Cryoport sees FY2023 revenue of $233-243 million, versus the consensus of $243 million.

For earnings history and earnings-related data on Cryoport (CYRX) click here.

You May Also Be Interested In

• FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
• Humanoid robot component stocks surge on supply-chain optimism
• Vistance Networks sells Ruckus Networks to Belden for ~$1.75B net